Literature DB >> 19597690

A feasible lifestyle program for early intervention in patients with chronic obstructive pulmonary disease (COPD): a pilot study in primary care.

Maria Fässberg Norrhall1, Anna Nilsfelt, Edgardo Varas, Ronny Larsson, Dan Curiac, Gösta Axelsson, Jörgen Månsson, Jonas Brisman, Anna-Lena Söderström, Cecilia Björkelund, Jörgen Thorn.   

Abstract

AIM: To evaluate the feasibility of a lifestyle program for early intervention in patients with COPD in a primary care population.
METHODS: The study was performed in a Primary Health Care Centre in Western Sweden. During a four-week period, all smokers between 40-70 years of age were invited to answer a questionnaire and to perform spirometry. The intervention program included a specially designed smoking cessation program and programs for physical activity and diet.
RESULTS: 84 smokers were included. 42% fulfilled the criteria for COPD. All of the COPD patients were in GOLD stage I and II. Among the COPD subjects, 38% were underweight and 56% had a low fat-free mass - both together indicating malnutrition and the need for nutritional treatment. By the end of the intervention program, 47% of the COPD patients had stopped smoking.
CONCLUSIONS: The intervention program was feasible and effective with a very high smoking cessation rate.

Entities:  

Mesh:

Year:  2009        PMID: 19597690      PMCID: PMC6619366          DOI: 10.4104/pcrj.2009.00041

Source DB:  PubMed          Journal:  Prim Care Respir J        ISSN: 1471-4418


  2 in total

1.  Patient-centred assessment of COPD in primary care: experience from a cross-sectional study of health-related quality of life in Europe.

Authors:  Paul W Jones; Guy Brusselle; Roberto W Dal Negro; Montse Ferrer; Peter Kardos; Mark L Levy; Thierry Perez; Juan José Soler Cataluña; Thys van der Molen; Lukasz Adamek; Norbert Banik
Journal:  Prim Care Respir J       Date:  2012-09

2.  Effective smoking cessation interventions for COPD patients: a review of the evidence.

Authors:  Sophie Coronini-Cronberg; Catherine Heffernan; Michael Robinson
Journal:  JRSM Short Rep       Date:  2011-10-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.